Yang‐Xin Fu

49.8k citations

377 papers · 37.9k indexed · 21 hit papers · h-index 99

Impact in

Immunology top 0.01%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immune cells in cancer
- Immune Response and Inflammation
- interferon and immune responses
Oncology top 0.05%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research

Papers in

Immunology 277
- Immune Cell Function and Interaction 140
- Immunotherapy and Immune Responses 140
- T-cell and B-cell Immunology 96
- Immune Response and Inflammation 30
- IL-33, ST2, and ILC Pathways 28
- Immune cells in cancer 24
Oncology 120
- Cancer Immunotherapy and Biomarkers 70
- CAR-T cell therapy research 46

Co-authors: Hans Schreiber Thomas F. Gajewski Ralph R. Weichselbaum Liufu Deng Hua Liang Byron Burnette David Chaplin Michael A. Beckett
Journals: The Journal of Immunology (47 papers)The Journal of Experimental Medicine (23 papers)Journal of Clinical Investigation (22 papers)Nature Communications (17 papers)Proceedings of the National Academy of Sciences (13 papers)
Partner nations: United States China Germany

In The Last Decade

Yang‐Xin Fu

370 papers receiving 37.5k citations

Hit Papers

15 papers align trajectories log scale

ILC3s regulate the gut microbiota via host intestinal galactosylation to limit pathogen infection in mice 2025 · 18 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2025 Nature Microbiology
2024 Science Immunology
2023 Nature Nanotechnology
2022 Nature Nanotechnology
2022 Nature Communications
2021 Cell Metabolism
2020 Nature Communications
2020 The Journal of Experimental Medicine
2019 Nature reviews. Cancer
2018 Nature Biomedical Engineering
2017 Nature Reviews Clinical Oncology
2016 Cancer Cell
2015 Nature Medicine
2014 Proceedings of the National Academy of Sciences
2014 Journal of Clinical Investigation
2014 Immunity
2013 Nature Immunology
2011 Immunity
2011 Cancer Research
2009 Blood
1999 Annual Review of Immunology

Peers

Countries citing papers authored by Yang‐Xin Fu

Since Specialization

Citations

This map shows the geographic impact of Yang‐Xin Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang‐Xin Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang‐Xin Fu more than expected).

Fields of papers citing papers by Yang‐Xin Fu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yang‐Xin Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang‐Xin Fu. The network helps show where Yang‐Xin Fu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yang‐Xin Fu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yang‐Xin Fu Line = papers co-authored together Yang‐Xin Fu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Eribulin and sintilimab combined with radiotherapy in a heavily pretreated patient with advanced retroperitoneal myxoid pleomorphic liposarcoma: a case report and literature review Frontiers in Oncology ·Е.Ю. Зуева, Dongna Li, Yang‐Xin Fu, Xinyao Zhang, Xin He, Ying Xu, Jie Liu, Yu Jiang, Yaotiao Deng	2025	0
2	A next-generation anti-CTLA-4 probody mitigates toxicity and enhances anti-tumor immunity in mice Nature Communications ·Rong Zhou, Junfan Chen, Yutong Fu, Qi Jiang, Iffah Izzati Humairoâ€TM, Olga Bautista, Yang‐Xin Fu, Wenyan Wang	2025	0
3	The toxic effects and mechanisms of maternal exposure to Bisphenol F during gestation and lactation on lungs in female offspring mice Environmental Pollution ·W Liu, Rong Shi, Bo Li, Xuliang Zhang, Jian Zhang, Yang‐Xin Fu, Bing Shao, Yanfei Li, Miao Song	2024	1
4	Facts and Hopes on Chimeric Cytokine Agents for Cancer Immunotherapy Clinical Cancer Research ·Zhenhua Ren, 康士峰 KANG Shifeng, Yang‐Xin Fu	2024	13
5	STING licensing of type I dendritic cells potentiates antitumor immunity Science Immunology ·Matteo Trentini, Suxin Li, Ivan Herych, Xu Wang, Shuqing Chen, Zhichen Sun, John Atherton Horsfall, Gang Huang, Baran D. Sumer, Nan Yan, Yang‐Xin Fu, Jinming Gao Hit paper breakdown →	2024	63
6	Chelerythrine induces apoptosis and ferroptosis through Nrf2 in ovarian cancercells Cellular and Molecular Biology ·Jia Zhou, Yuchen Wang, Yang‐Xin Fu, Zhe Lin, A. Čerevková, Wilson W.S. Poon, Ning Kong, Xin Guo, Fang Zhou, Zhidong Qiu, Xiaowei Huang	2024	7
7	Investigation of Antigen-Specific T-Cell Receptor Clusters in Human Cancers Clinical Cancer Research ·Hongyi Zhang, Longchao Liu, Jian Zhang, Jiahui Chen, Jianfeng Ye, Sachet A. Shukla, Jian Qiao, Xiaowei Zhan, Hao Chen, Catherine J. Wu, Yang‐Xin Fu, Bo Li	2019	99
8	LIGHT Elevation Enhances Immune Eradication of Colon Cancer Metastases Cancer Research ·Guilin Qiao, Jian‐Zhong Qin, 王恒博, Nawaf Aldawsari, Dolores Mahmud, Peter H. Gann, Yang‐Xin Fu, Steven A. Rosenberg, Bellur S. Prabhakar, Ajay V. Maker	2017	34
9	CTLA-4 Limits Anti-CD20–Mediated Tumor Regression Clinical Cancer Research ·Zhenhua Ren, Jingya Guo, Jing Liao, Yan Luan, Zhida Liu, Zhichen Sun, Friedel H. Schwartz, Yong Liang, Hua Peng, Yang‐Xin Fu	2016	34
10	Commensal bacteria protect against food allergen sensitization Proceedings of the National Academy of Sciences ·Andrew Stefka, Taylor Feehley, Prabhanshu Tripathi, Ju Qiu, Kathy D. McCoy, Sarkis K. Mazmanian, Melissa Y. Tjota, Goo‐Young Seo, Severine Cao, Betty Theriault, Dionysios A. Antonopoulos, Liang Zhou, Eugene B. Chang, Yang‐Xin Fu, Cathryn R. Nagler Hit paper breakdown →	2014	590
11	Anti-HER2/Neu passive-aggressive immunotherapy OncoImmunology ·Eric D. Mortenson, Yang‐Xin Fu	2014	3
12	Antigen-Specific Bacterial Vaccine Combined with Anti-PD-L1 Rescues Dysfunctional Endogenous T Cells to Reject Long-Established Cancer Cancer Immunology Research ·David C. Binder, Boris Engels, Ainhoa Arina, Ping Yü, James M. Slauch, Yang‐Xin Fu, Theodore Karrison, Byron Burnette, Christian Idel, Ming Zhao, Robert M. Hoffman, David H. Munn, Donald A. Rowley, Hans Schreiber	2013	65
13	LIGHT Delivery to Tumors by Mesenchymal Stem Cells Mobilizes an Effective Antitumor Immune Response Cancer Research ·Gopi Krishna Vutla, Huilin Zheng, Tong‐Chuan He, S Muanza, Yang‐Xin Fu, Weimin Fan	2012	40
14	Antigen persistence and the control of local T cell memory by migrant respiratory dendritic cells after acute virus infection The Journal of Experimental Medicine ·Taeg S. Kim, Matthew M. Hufford, Jie Sun, Yang‐Xin Fu, Thomas J. Braciale	2010	147
15	Tumor masses support naive T cell infiltration, activation, and differentiation into effectors The Journal of Experimental Medicine ·Elizabeth D. Thompson, Wenhua Qiu, Yang‐Xin Fu, Víctor H. Engelhard	2010	196
16	Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment Blood ·Youjin Lee, Sogyong Auh, Yugang Wang, Byron Burnette, Yang Wang, Yuru Meng, Michael A. Beckett, Rohit Sharma, Robert Chin, Tony Tu, Ralph R. Weichselbaum, Yang‐Xin Fu Hit paper breakdown →	2009	1050
17	Equilibrium between Host and Cancer Caused by Effector T Cells Killing Tumor Stroma Cancer Research ·Bin Zhang, Yi Zhang, Natalie A. Bowerman, Andrea Schietinger, Yang‐Xin Fu, David M. Kranz, Donald A. Rowley, Hans Schreiber	2008	59
18	Recognition of Host Immune Activation by Pseudomonas aeruginosa Science ·Licheng Wu, Oscar Estrada, Olga Zaborina, Manjeet Bains, Le Shen, Jonathan E. Kohler, Nachiket Patel, Mark W. Musch, Eugene B. Chang, Yang‐Xin Fu, Michael A. Jacobs, Michael I. Nishimura, Robert E. W. Hancock, Jerrold R. Turner, John C. Alverdy	2005	256
19	Blockade of LIGHT/LTβ and CD40 signaling induces allospecific T cell anergy, preventing graft-versus-host disease Journal of Clinical Investigation ·Koji Tamada, Hideto Tamura, Dallas B. Flies, Yang‐Xin Fu, Esteban Celis, Larry R. Pease, Bruce R. Blazar, Lieping Chen	2002	70
20	Blockade of LIGHT/LTβ and CD40 signaling induces allospecific T cell anergy, preventing graft-versus-host disease Journal of Clinical Investigation ·Koji Tamada, Hideto Tamura, Dallas B. Flies, Yang‐Xin Fu, Esteban Celis, Larry R. Pease, Bruce R. Blazar, Lieping Chen	2002	18

About Yang‐Xin Fu

Yang‐Xin Fu is a scholar working on Immunology, Oncology, Hepatology, Immunology and Allergy and Radiology, Nuclear Medicine and Imaging, having authored 377 papers that have together received 37.9k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (140 papers), Immunotherapy and Immune Responses (140 papers), T-cell and B-cell Immunology (96 papers), Cancer Immunotherapy and Biomarkers (70 papers), CAR-T cell therapy research (46 papers), Immune Response and Inflammation (30 papers), IL-33, ST2, and ILC Pathways (28 papers) and Immune cells in cancer (24 papers). The work is most often cited by research in Immunology (22.5k citations), Oncology (14.2k citations), Cancer Research (3.0k citations), Biological Psychiatry (368 citations) and Molecular Biology (9.8k citations). Yang‐Xin Fu has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Hans Schreiber, Thomas F. Gajewski, Ralph R. Weichselbaum, Liufu Deng, Hua Liang, Byron Burnette, David Chaplin, Michael A. Beckett, Ping Yu and Thomas E. Darga. Their work appears in journals such as The Journal of Immunology, The Journal of Experimental Medicine, Journal of Clinical Investigation, Nature Communications and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact